{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:05Z","timestamp":1792807505977,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jinf.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T03:34:20Z","timestamp":1539660860000},"page":"469-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-0783","authenticated-orcid":false,"given":"Ivan Surya","family":"Pradipta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Davies","family":"Forsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.10.004_bib0001","unstructured":"WHO. WHO Global tuberculosis report 2017. 2017."},{"key":"10.1016\/j.jinf.2018.10.004_bib0002","unstructured":"WHO. WHO | Global tuberculosis report 2016. 2015."},{"key":"10.1016\/j.jinf.2018.10.004_bib0003","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tig.2012.11.005","article-title":"The heterogeneous evolution of multidrug-resistant mycobacterium tuberculosis","author":"M\u01d8ller","year":"2013","journal-title":"Trends Genet"},{"key":"10.1016\/j.jinf.2018.10.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.cegh.2015.10.005","article-title":"Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis","author":"Singh","year":"2015","journal-title":"Clin Epidemiol Glob Heal"},{"key":"10.1016\/j.jinf.2018.10.004_bib0005","year":"2014","journal-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis"},{"issue":"8","key":"10.1016\/j.jinf.2018.10.004_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0071867","article-title":"Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors","volume":"8","author":"Hang","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jinf.2018.10.004_bib0007","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10096-011-1167-4","article-title":"Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-Resistant tuberculosis","volume":"30","author":"Fox","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2018.10.004_bib0008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/00365548.2011.611169","article-title":"Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients","volume":"44","author":"Vadwai","year":"2012","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2018.10.004_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0139986","article-title":"Risk factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis at the central chest institute of Thailand","volume":"10","author":"Chuchottaworn","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jinf.2018.10.004_bib0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3855\/jidc.6162","article-title":"Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study","volume":"9","author":"Elmi","year":"2015","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"10.1016\/j.jinf.2018.10.004_bib0011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/mdr.2009.0906","article-title":"Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa","volume":"15","author":"Diand\u00e9","year":"2009","journal-title":"Microb Drug Resist"},{"issue":"2","key":"10.1016\/j.jinf.2018.10.004_bib0012","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/147323001204000205","article-title":"Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis","volume":"40","author":"Zhao","year":"2012","journal-title":"J Int Med Res"},{"issue":"12","key":"10.1016\/j.jinf.2018.10.004_bib0013","first-page":"1424","article-title":"Meta-analysis on risk factors of multidrug resitant tuberculosis in China","volume":"36","author":"Cai","year":"2015","journal-title":"Chin J Epidemiol"},{"key":"10.1016\/j.jinf.2018.10.004_bib0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"Faustini","year":"2006","journal-title":"Thorax"},{"issue":"291","key":"10.1016\/j.jinf.2018.10.004_bib0015","first-page":"1\/13","article-title":"Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"15","author":"Lukoye","year":"2015","journal-title":"BioMed Cent"},{"issue":"7","key":"10.1016\/j.jinf.2018.10.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2018.10.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.5","article-title":"Pathogen-host-environment interplay and disease emergence","author":"Engering","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"10.1016\/j.jinf.2018.10.004_bib0018","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ptj\/85.3.257","article-title":"The kappa statistic in reliability studies: use, interpretation, and sample size requirements","volume":"85","author":"Sim","year":"2005","journal-title":"Phys Ther"},{"issue":"4","key":"10.1016\/j.jinf.2018.10.004_bib0019","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"March","key":"10.1016\/j.jinf.2018.10.004_bib0020","first-page":"10","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]","volume":"0","author":"Higgins","year":"2011","journal-title":"Cochrane Collab"},{"issue":"June","key":"10.1016\/j.jinf.2018.10.004_bib0021","first-page":"1","article-title":"Meta-analyses: heterogeneity and subgroup analysis","volume":"346","author":"Sedgwick","year":"2013","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.jinf.2018.10.004_bib0022","first-page":"430","article-title":"Multidrug-resistant Mycobacterium tuberculosis at a referral center for infectious diseases in the state of Minas Gerais, Brazil: sensitivity profile and related risk factors","volume":"32","author":"de Souza","year":"2006","journal-title":"J Bras Pneumol"},{"issue":"1","key":"10.1016\/j.jinf.2018.10.004_bib0023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jinf.2005.10.002","article-title":"Drug-resistant tuberculosis: a disease of target populations in Houston, Texas","volume":"53","author":"El Sahly","year":"2006","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2018.10.004_bib0024","first-page":"17","article-title":"Risk factors associated with multidrug-resistant tuberculosis","volume":"8","author":"Baghaei","year":"2009","journal-title":"Tanaffos"},{"issue":"10","key":"10.1016\/j.jinf.2018.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.5588\/ijtld.14.0192","article-title":"Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes","volume":"18","author":"Mor","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.10.004_bib0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijmyco.2012.07.007","article-title":"Risk factors for multidrug-resistant tuberculosis in urban Pakistan: a multicenter case-control study","volume":"1","author":"Ahmad","year":"2012","journal-title":"Int J Mycobacteriology"},{"issue":"1","key":"10.1016\/j.jinf.2018.10.004_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijmyco.2015.11.001","article-title":"Previous treatment, sputum-smear nonconversion, and suburban living: the risk factors of multidrug-resistant tuberculosis among Malaysians","volume":"5","author":"Mohd","year":"2016","journal-title":"Int J Mycobacteriol"},{"issue":"23","key":"10.1016\/j.jinf.2018.10.004_bib0028","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jinf.2018.10.004_bib0029","first-page":"253","article-title":"Drug-resistant tuberculosis in Shanghai, China, 2000-2006: Prevalence, trends and risk factors","volume":"13","author":"Shen","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.10.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0009527","article-title":"Risk factors for MDR and XDR-TB in a tertiary referral hospital in India","volume":"5","author":"Balaji","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jinf.2018.10.004_bib0031","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1086\/650311","article-title":"Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia","volume":"201","author":"Parwati","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.10.004_bib0032","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3201\/eid0912.030169","article-title":"Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam","author":"Lan","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"10.1016\/j.jinf.2018.10.004_bib0033","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1001\/jama.293.22.2726","article-title":"Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia","volume":"293","author":"Drobniewski","year":"2005","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.jinf.2018.10.004_bib0034","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.2004.02551.x","article-title":"Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different mycobacterium tuberculosis genotypes in a BALB\/c mouse model","volume":"137","author":"Dormans","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2018.10.004_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(09)70330-5","article-title":"Possible underlying mechanisms for successful emergence of the mycobacterium tuberculosis Beijing genotype strains","author":"Parwati","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2018.10.004_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005561","article-title":"Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review","author":"Suchindran","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2018.10.004_bib0037","first-page":"24","article-title":"Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection","volume":"15","author":"Houben Rein","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1016\/j.jinf.2018.10.004_bib0038","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1469-0691.2004.00758.x","article-title":"Tuberculosis in HIV-infected patients: a comprehensive review","volume":"10","author":"Aaron","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.jinf.2018.10.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135205","article-title":"Multidrug-resistant tuberculosis in patients with chronic obstructive pulmonary disease in China","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.10.004_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pone.0010138","article-title":"COPD and the risk of tuberculosis - a population-based cohort study","volume":"5","author":"Inghammar","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jinf.2018.10.004_bib0041","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.12-1225","article-title":"Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD","volume":"143","author":"Kim","year":"2013","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.jinf.2018.10.004_bib0042","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/infdis\/jir658","article-title":"Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability","volume":"204","author":"Srivastava","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.10.004_bib0043","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/cis353","article-title":"Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy","author":"Pasipanodya","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.10.004_bib0044","first-page":"89","article-title":"Role of pharmacogenomics in the treatment of tuberculosis: a review","author":"Ramachandran","year":"2012","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.jinf.2018.10.004_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American thoracic society \/ centers for disease control and prevention \/ infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis Guidel"},{"issue":"12","key":"10.1016\/j.jinf.2018.10.004_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0015735","article-title":"Predictors of multidrug-and extensively drug-resistant tuberculosis in a high HIV prevalence community","volume":"5","author":"Andrews","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jinf.2018.10.004_bib0047","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3201\/eid1707.101797","article-title":"Multidrug-resistant mycobacterium tuberculosis, southwestern Colombia","volume":"17","author":"Ferro","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2018.10.004_bib0048","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12890-016-0187-3","article-title":"Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with standard short-course chemotherapy for tuberculosis","volume":"16","author":"Gao","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"10","key":"10.1016\/j.jinf.2018.10.004_bib0049","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3201\/eid1710.110546","article-title":"Multidrug-resistant tuberculosis, People's Republic of China, 2007\u20132009","volume":"17","author":"He","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2018.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0003173","article-title":"Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study","volume":"3","author":"O'Riordan","year":"2008","journal-title":"PLoS One"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318303074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318303074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:19Z","timestamp":1759008379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318303074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0163445318303074"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.10.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}